NLS Acquisition

AddLife has acquired CoaChrom Diagnostica, an Austrian niche company specializing in advanced coagulation diagnostics.

Saga Diagnostics has entered into an agreement to be acquired by Foundation Medicine, an independent subsidiary of Roche, for a deal value of up to USD 595 million, including commercial and regulatory milestone payments.

Getinge has acquired Pennamed, a UK-based distributor of endoscopic consumables serving National Health Service (NHS) and independent healthcare providers.

MSD and Terns Pharmaceuticals have entered into a definitive agreement under which MSD, through a subsidiary, will acquire Terns for an approximate equity value of USD 6.7 billion.

Centessa is advancing a pipeline of orexin receptor 2 (OX2R) agonists designed to address the neurobiological system critical to the sleep-wake cycle to treat excessive daytime sleepiness and disorders of impaired wakefulness.

The two companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for USD 41.00 per share in cash at closing, or approximately USD 5.6 billion.